![](/img/cover-not-exists.png)
465: More Adverse Events Leading to Drug Dose Adjustment/Interruption in the Presence of MMF- vs Everolimus-Based Immunosuppression in De Novo Heart Transplant Patients
E. Vermes, L. Almenar, M. Viganò, M. MacCherini, A. Poncelet, M.-F. Mattei, T. Dengler, J. Delgado, J. Vanhaecke, M. Hexham, K. MangeVolume:
27
Year:
2008
Language:
english
DOI:
10.1016/j.healun.2007.11.478
File:
PDF, 79 KB
english, 2008